tiprankstipranks
Trending News
More News >
Aplix Corp (JP:3727)
:3727
Japanese Market
Advertisement

Aplix Corp (3727) AI Stock Analysis

Compare
1 Followers

Top Page

JP:3727

Aplix Corp

(3727)

Select Model
Select Model
Select Model
Neutral 67 (OpenAI - 4o)
Rating:67Neutral
Price Target:
¥201.00
▲(14.86% Upside)
Aplix Corp's overall stock score reflects a stable financial position with strong equity backing and efficient cash flow management. However, recent declines in profitability and inconsistent growth present challenges. Technical indicators suggest weak momentum, and the valuation is moderate, offering limited appeal for income-focused investors.

Aplix Corp (3727) vs. iShares MSCI Japan ETF (EWJ)

Aplix Corp Business Overview & Revenue Model

Company DescriptionAplix Corp (3727) is a Japanese company that specializes in the development and manufacturing of advanced adhesive solutions and materials, primarily serving the automotive, electronics, and construction sectors. The company is known for its innovative products that enhance adhesion, durability, and performance in a variety of applications. Aplix's core offerings include pressure-sensitive adhesives, sealants, and other bonding agents that cater to the needs of its diverse clientele.
How the Company Makes MoneyAplix Corp generates revenue primarily through the sale of its adhesive products to various industries, including automotive, electronics, and construction. The company has established key partnerships with major manufacturers in these sectors, allowing it to secure long-term contracts and bulk orders. Additionally, Aplix invests in research and development to create innovative solutions that meet evolving market demands, which helps to maintain its competitive edge. The company also benefits from a strong distribution network that ensures its products reach a wide customer base, contributing to consistent sales and revenue growth.

Aplix Corp Financial Statement Overview

Summary
Aplix Corp exhibits a stable financial position with strong equity backing and efficient cash flow management. Despite recent declines in profitability metrics, the company maintains good operating margins and a conservative leverage structure. Growth has been inconsistent, reflecting potential market or operational challenges.
Income Statement
72
Positive
Aplix Corp shows a mixed performance. The gross profit margin is strong at 28.73% for 2024, indicating efficient cost management relative to revenue. However, the net profit margin decreased significantly to 4.24% from 8.93% in 2023, reflecting reduced profitability. Revenue growth has been volatile, with a decline of 1.44% in 2024, after previous growth. The EBIT and EBITDA margins remained healthy at 6.12% and 9.22% respectively, but both experienced declines compared to 2023, suggesting operating challenges.
Balance Sheet
80
Positive
The balance sheet depicts a strong financial position. The debt-to-equity ratio remains low at 0.21, indicating conservative leverage. Return on equity decreased to 6.05% compared to 13.18% in 2023, showing a dip in shareholder returns. The equity ratio is robust at 66.78%, highlighting solid financial stability with substantial equity backing the assets.
Cash Flow
75
Positive
Cash flow analysis reveals healthy operating cash flow with a ratio of 2.01 to net income, indicating good cash generation relative to earnings. The free cash flow to net income ratio is also strong at 2.01. However, the free cash flow growth rate of 26.12% in 2024 reflects a slowdown compared to 2023's 68.25%, suggesting potential constraints in cash generation growth.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue3.31B3.71B3.76B3.50B3.50B3.38B
Gross Profit1.06B1.06B858.00M742.74M711.82M1.01B
EBITDA371.32M346.43M376.00M154.84M8.55M176.56M
Net Income148.75M157.08M336.04M185.66M-106.74M84.22M
Balance Sheet
Total Assets3.74B3.89B3.27B2.96B2.77B3.13B
Cash, Cash Equivalents and Short-Term Investments1.26B1.32B1.81B1.47B1.34B1.31B
Total Debt493.18M550.65M149.51M167.14M200.00M200.00M
Total Liabilities1.16B1.29B718.77M750.60M713.00M966.32M
Stockholders Equity2.58B2.59B2.55B2.20B2.05B2.16B
Cash Flow
Free Cash Flow481.33M176.07M249.79M431.93M43.01M-288.40M
Operating Cash Flow481.33M316.59M251.81M435.03M59.86M-285.90M
Investing Cash Flow-235.60M-1.06B-82.69M-82.69M-34.75M-14.00M
Financing Cash Flow-251.61M258.59M-17.84M-17.84M3.06M197.77M

Aplix Corp Technical Analysis

Technical Analysis Sentiment
Negative
Last Price175.00
Price Trends
50DMA
192.60
Negative
100DMA
172.91
Positive
200DMA
160.53
Positive
Market Momentum
MACD
-2.74
Positive
RSI
44.33
Neutral
STOCH
22.81
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3727, the sentiment is Negative. The current price of 175 is below the 20-day moving average (MA) of 181.00, below the 50-day MA of 192.60, and above the 200-day MA of 160.53, indicating a neutral trend. The MACD of -2.74 indicates Positive momentum. The RSI at 44.33 is Neutral, neither overbought nor oversold. The STOCH value of 22.81 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:3727.

Aplix Corp Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
67
Neutral
¥3.91B26.271.43%-12.15%-10.32%
62
Neutral
¥3.35B17.303.81%42.88%-5.21%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
55
Neutral
¥2.82B96.253.30%16.83%-86.95%
51
Neutral
¥3.09B10.25-8.20%
50
Neutral
¥2.81B-24.70-4.34%-1012.18%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:3727
Aplix Corp
175.00
13.01
8.03%
JP:3909
Showcase, Inc. (Japan)
303.00
-31.00
-9.28%
JP:4174
Appirits Inc.
666.00
-35.38
-5.04%
JP:4387
ZUU Co., Ltd.
609.00
-144.00
-19.12%
JP:4447
PBsystems, Inc.
525.00
-65.00
-11.02%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 30, 2025